Abstract
The total daily dose of theophylline required to achieve a four-hour steady-state serum concentration within the 10–20 μg/ml therapeutic range was examined for 49 age-matched pairs of female and male children, age 5–15 years, with chronic asthma. All patients received the same 100 percent bioavailable slow-release product (Theodur®) at eight-hour intervals for more than 72 hours. Total body clearance of theophylline was estimated from the four-hour measurement which closely approximated the average serum concentration. A clinical pharmacist interviewed all patients or parents before a blood sample was obtained to document compliance and other factors that might alter the interpretation and reliability of the measurement.
Get full access to this article
View all access options for this article.